Valerie E. Walker

Papers

Total Citations

H-Index

About

Valerie E. Walker is a molecular biologist whose research centers on cardiac electrophysiology and the cellular mechanisms underlying arrhythmogenic disorders. Her most influential work investigates the biogenesis and trafficking of the HERG potassium channel, a critical regulator of cardiac repolarization. In her landmark 2007 study, cited 96 times, Walker demonstrated that the co-chaperone FKBP38 is essential for proper HERG channel trafficking to the cell membrane, a process whose disruption is a primary cause of Long QT Syndrome—a condition predisposing patients to life-threatening ventricular arrhythmias, syncope, and sudden cardiac death. This discovery provided a mechanistic link between molecular chaperone dysfunction and inherited arrhythmia syndromes, offering new therapeutic targets for channelopathies. Beyond this seminal contribution, her broader research portfolio explores how mutations in the KCNH2 gene impair IKr currents, deepening our understanding of genotype-phenotype correlations in cardiac disease. Walker’s work has been instrumental in bridging basic channel biology with clinical cardiology, earning her recognition as a key figure in the study of HERG channelopathies. Her findings continue to inform drug safety screening and personalized medicine approaches for Long QT Syndrome patients.